Cargando…
Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease
Humanity is facing a vast prevalence of neurodegenerative diseases, with Alzheimer’s disease (AD) being the most dominant, without efficacious drugs, and with only a few therapeutic targets identified. In this scenario, we aim to find molecular entities that modulate imidazoline I(2) receptors (I(2)...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610545/ https://www.ncbi.nlm.nih.gov/pubmed/37896141 http://dx.doi.org/10.3390/pharmaceutics15102381 |